

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.72713361 |
| 2 | cerebellar granule cell differentiation (GO:0021707) | 4.90383133 |
| 3 | central nervous system myelination (GO:0022010) | 4.87412041 |
| 4 | axon ensheathment in central nervous system (GO:0032291) | 4.87412041 |
| 5 | L-amino acid import (GO:0043092) | 4.83030057 |
| 6 | positive regulation of synapse maturation (GO:0090129) | 4.70475818 |
| 7 | positive regulation of dendritic spine development (GO:0060999) | 4.46197040 |
| 8 | amino acid import (GO:0043090) | 4.29804422 |
| 9 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.16659710 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.07909563 |
| 11 | presynaptic membrane organization (GO:0097090) | 4.07827790 |
| 12 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.95968032 |
| 13 | synaptic vesicle endocytosis (GO:0048488) | 3.93663185 |
| 14 | positive regulation of membrane potential (GO:0045838) | 3.84708098 |
| 15 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.83974435 |
| 16 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.79938871 |
| 17 | regulation of synapse maturation (GO:0090128) | 3.78708806 |
| 18 | neuromuscular process controlling balance (GO:0050885) | 3.71882329 |
| 19 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.69451680 |
| 20 | synaptic vesicle exocytosis (GO:0016079) | 3.69393217 |
| 21 | dendritic spine organization (GO:0097061) | 3.65314325 |
| 22 | locomotory exploration behavior (GO:0035641) | 3.64731856 |
| 23 | regulation of neurotransmitter secretion (GO:0046928) | 3.63469154 |
| 24 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.59476200 |
| 25 | gamma-aminobutyric acid transport (GO:0015812) | 3.56482471 |
| 26 | neuronal action potential propagation (GO:0019227) | 3.56019611 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 3.55867275 |
| 28 | regulation of postsynaptic membrane potential (GO:0060078) | 3.54465475 |
| 29 | mechanosensory behavior (GO:0007638) | 3.54138731 |
| 30 | synaptic vesicle maturation (GO:0016188) | 3.53273416 |
| 31 | neurotransmitter uptake (GO:0001504) | 3.52578204 |
| 32 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.51880525 |
| 33 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.51465986 |
| 34 | regulation of synaptic plasticity (GO:0048167) | 3.51439154 |
| 35 | acidic amino acid transport (GO:0015800) | 3.48646621 |
| 36 | regulation of dendritic spine development (GO:0060998) | 3.46756769 |
| 37 | cell migration in hindbrain (GO:0021535) | 3.42316915 |
| 38 | regulation of neurotransmitter transport (GO:0051588) | 3.41206938 |
| 39 | alanine transport (GO:0032328) | 3.35092660 |
| 40 | neuron cell-cell adhesion (GO:0007158) | 3.34580675 |
| 41 | vocalization behavior (GO:0071625) | 3.30072102 |
| 42 | endocrine pancreas development (GO:0031018) | 3.28949201 |
| 43 | neurotransmitter secretion (GO:0007269) | 3.26294834 |
| 44 | positive regulation of neurotransmitter transport (GO:0051590) | 3.24587215 |
| 45 | establishment of mitochondrion localization (GO:0051654) | 3.24466275 |
| 46 | regulation of ARF protein signal transduction (GO:0032012) | 3.24114360 |
| 47 | cell communication by electrical coupling (GO:0010644) | 3.21875301 |
| 48 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.19007954 |
| 49 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.17418326 |
| 50 | membrane depolarization (GO:0051899) | 3.15169144 |
| 51 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.10547424 |
| 52 | L-glutamate transport (GO:0015813) | 3.10464555 |
| 53 | cell differentiation in hindbrain (GO:0021533) | 3.09057132 |
| 54 | long-term memory (GO:0007616) | 3.08537883 |
| 55 | positive regulation of dendrite development (GO:1900006) | 3.08485411 |
| 56 | membrane depolarization during action potential (GO:0086010) | 3.05180855 |
| 57 | regulation of synaptic transmission (GO:0050804) | 3.04203416 |
| 58 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.02869185 |
| 59 | glutamate secretion (GO:0014047) | 3.00676460 |
| 60 | COPI coating of Golgi vesicle (GO:0048205) | 3.00554914 |
| 61 | Golgi transport vesicle coating (GO:0048200) | 3.00554914 |
| 62 | cellular potassium ion homeostasis (GO:0030007) | 2.99485834 |
| 63 | synaptic vesicle transport (GO:0048489) | 2.98865811 |
| 64 | establishment of synaptic vesicle localization (GO:0097480) | 2.98865811 |
| 65 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.97631541 |
| 66 | regulation of female receptivity (GO:0045924) | 2.96778230 |
| 67 | membrane hyperpolarization (GO:0060081) | 2.96133892 |
| 68 | cerebellar Purkinje cell layer development (GO:0021680) | 2.95770083 |
| 69 | adult walking behavior (GO:0007628) | 2.95307084 |
| 70 | synaptic transmission (GO:0007268) | 2.93492691 |
| 71 | detection of calcium ion (GO:0005513) | 2.89285256 |
| 72 | protein maturation by protein folding (GO:0022417) | 2.86797205 |
| 73 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.84450572 |
| 74 | insulin secretion (GO:0030073) | 2.83457011 |
| 75 | negative regulation of catecholamine secretion (GO:0033604) | 2.81507798 |
| 76 | proline transport (GO:0015824) | 2.80944285 |
| 77 | exploration behavior (GO:0035640) | 2.80763289 |
| 78 | layer formation in cerebral cortex (GO:0021819) | 2.80669424 |
| 79 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.78905299 |
| 80 | dendritic spine morphogenesis (GO:0060997) | 2.78013949 |
| 81 | peptide hormone processing (GO:0016486) | 2.77198461 |
| 82 | regulation of synaptic vesicle transport (GO:1902803) | 2.74315815 |
| 83 | regulation of beta-amyloid formation (GO:1902003) | 2.72320203 |
| 84 | nitric oxide mediated signal transduction (GO:0007263) | 2.71332050 |
| 85 | neurotransmitter transport (GO:0006836) | 2.70453595 |
| 86 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.67566144 |
| 87 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.66885343 |
| 88 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.66626785 |
| 89 | postsynaptic membrane organization (GO:0001941) | 2.66459014 |
| 90 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.65914234 |
| 91 | positive regulation of insulin secretion (GO:0032024) | 2.65876372 |
| 92 | auditory behavior (GO:0031223) | 2.64917887 |
| 93 | sodium ion export (GO:0071436) | 2.63951530 |
| 94 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.63187712 |
| 95 | activation of protein kinase A activity (GO:0034199) | 2.63155130 |
| 96 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.62581007 |
| 97 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.61398335 |
| 98 | regulation of vesicle fusion (GO:0031338) | 2.59673229 |
| 99 | neuron recognition (GO:0008038) | 2.58428055 |
| 100 | regulation of insulin secretion (GO:0050796) | 2.57091663 |
| 101 | response to auditory stimulus (GO:0010996) | 2.56908961 |
| 102 | regulation of neurotransmitter levels (GO:0001505) | 2.56621639 |
| 103 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.56268715 |
| 104 | transmission of nerve impulse (GO:0019226) | 2.54342742 |
| 105 | cellular response to glucagon stimulus (GO:0071377) | 2.53959354 |
| 106 | neuromuscular process controlling posture (GO:0050884) | 2.53229773 |
| 107 | regulation of synapse structural plasticity (GO:0051823) | 2.52277664 |
| 108 | protein localization to synapse (GO:0035418) | 2.50392595 |
| 109 | potassium ion import (GO:0010107) | 2.49484540 |
| 110 | cochlea development (GO:0090102) | 2.46286878 |
| 111 | C4-dicarboxylate transport (GO:0015740) | 2.45241752 |
| 112 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.45177022 |
| 113 | presynaptic membrane assembly (GO:0097105) | 2.44982870 |
| 114 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.44312323 |
| 115 | potassium ion homeostasis (GO:0055075) | 2.44272577 |
| 116 | dendrite morphogenesis (GO:0048813) | 2.43894143 |
| 117 | innervation (GO:0060384) | 2.43381066 |
| 118 | synaptic transmission, glutamatergic (GO:0035249) | 2.42899879 |
| 119 | cellular sodium ion homeostasis (GO:0006883) | 2.40946683 |
| 120 | response to dietary excess (GO:0002021) | 2.39485744 |
| 121 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.39387470 |
| 122 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.37828834 |
| 123 | regulation of peptide hormone secretion (GO:0090276) | 2.35798927 |
| 124 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.34996915 |
| 125 | regulation of peptide secretion (GO:0002791) | 2.34317234 |
| 126 | glutamate receptor signaling pathway (GO:0007215) | 2.34128004 |
| 127 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.33225470 |
| 128 | regulation of respiratory system process (GO:0044065) | 2.33070930 |
| 129 | positive regulation of peptide secretion (GO:0002793) | 2.32777634 |
| 130 | signal release (GO:0023061) | 2.31738357 |
| 131 | positive regulation of peptide hormone secretion (GO:0090277) | 2.31565108 |
| 132 | L-phenylalanine catabolic process (GO:0006559) | 2.31481441 |
| 133 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.31481441 |
| 134 | positive regulation of exocytosis (GO:0045921) | 2.30051705 |
| 135 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.29327098 |
| 136 | axonal fasciculation (GO:0007413) | 2.29249341 |
| 137 | neuronal ion channel clustering (GO:0045161) | 2.28230525 |
| 138 | negative regulation of norepinephrine secretion (GO:0010700) | 2.27414056 |
| 139 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.25583687 |
| 140 | cellular response to leptin stimulus (GO:0044320) | 2.25305430 |
| 141 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.25007602 |
| 142 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.24810332 |
| 143 | cellular zinc ion homeostasis (GO:0006882) | 2.24245782 |
| 144 | negative regulation of astrocyte differentiation (GO:0048712) | 2.23871585 |
| 145 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.23585502 |
| 146 | response to leptin (GO:0044321) | 2.23351544 |
| 147 | synapse assembly (GO:0007416) | 2.23153314 |
| 148 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.22497720 |
| 149 | cholesterol catabolic process (GO:0006707) | 2.21990584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.99580105 |
| 2 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.99844368 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.94789674 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.78399045 |
| 5 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.74634127 |
| 6 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.60708307 |
| 7 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.58300571 |
| 8 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.56791374 |
| 9 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.54420779 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.54379137 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.54379137 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.52305113 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51347109 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.46406649 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.42624940 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.42185706 |
| 17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.41189013 |
| 18 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 2.37223611 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.33004513 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13637285 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.08612177 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.06912186 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.01956701 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.92822136 |
| 25 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.84715282 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.83119774 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82153938 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.81544380 |
| 29 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.80248424 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.62570679 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57833612 |
| 32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.50709104 |
| 33 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.47526270 |
| 34 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.47095554 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44489794 |
| 36 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42335278 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.40415300 |
| 38 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.40051380 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.37284264 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.34901972 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31450924 |
| 42 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30812848 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.30115884 |
| 44 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.28386459 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28284297 |
| 46 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28020814 |
| 47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.25438990 |
| 48 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.24671140 |
| 49 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23231974 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22273601 |
| 51 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.20610334 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19382419 |
| 53 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.19001893 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18427224 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18312416 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16575503 |
| 57 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.15956050 |
| 58 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.15927600 |
| 59 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.11816699 |
| 60 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.10220612 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.09682430 |
| 62 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.08740936 |
| 63 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06834412 |
| 64 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.05279072 |
| 65 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05075955 |
| 66 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.03457496 |
| 67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03420805 |
| 68 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02446901 |
| 69 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02101590 |
| 70 | P300_19829295_ChIP-Seq_ESCs_Human | 1.01474998 |
| 71 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01144142 |
| 72 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.00089852 |
| 73 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99987349 |
| 74 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99721166 |
| 75 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.98977830 |
| 76 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98436558 |
| 77 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98197284 |
| 78 | AR_19668381_ChIP-Seq_PC3_Human | 0.98090158 |
| 79 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.97813961 |
| 80 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97165209 |
| 81 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.97117368 |
| 82 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95862480 |
| 83 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.93339313 |
| 84 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92367833 |
| 85 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91913385 |
| 86 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91844515 |
| 87 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91721008 |
| 88 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91621384 |
| 89 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91482309 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.90662315 |
| 91 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90544659 |
| 92 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90392245 |
| 93 | STAT3_23295773_ChIP-Seq_U87_Human | 0.90051625 |
| 94 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.88341865 |
| 95 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87693872 |
| 96 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.86898781 |
| 97 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.86824656 |
| 98 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.86415381 |
| 99 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86261032 |
| 100 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85901862 |
| 101 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.85358728 |
| 102 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.85325340 |
| 103 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.84982625 |
| 104 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.84941691 |
| 105 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84416322 |
| 106 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84188513 |
| 107 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.83819180 |
| 108 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82318853 |
| 109 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81333222 |
| 110 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.80946520 |
| 111 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.80683745 |
| 112 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.80194165 |
| 113 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.79373407 |
| 114 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78640311 |
| 115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78346728 |
| 116 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.78296737 |
| 117 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.78292889 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.77843054 |
| 119 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.77683407 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.77413487 |
| 121 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.77310229 |
| 122 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77177738 |
| 123 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.77026742 |
| 124 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74499514 |
| 125 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.73597685 |
| 126 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.73309327 |
| 127 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.73176617 |
| 128 | P68_20966046_ChIP-Seq_HELA_Human | 0.72277976 |
| 129 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.71697716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.27642773 |
| 2 | MP0009780_abnormal_chondrocyte_physiolo | 3.21887380 |
| 3 | MP0004270_analgesia | 3.01906852 |
| 4 | MP0002909_abnormal_adrenal_gland | 2.94216176 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 2.74689609 |
| 6 | MP0003283_abnormal_digestive_organ | 2.67623978 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.34691685 |
| 8 | MP0003880_abnormal_central_pattern | 2.30660217 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.19546132 |
| 10 | MP0003329_amyloid_beta_deposits | 2.19066883 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.17491023 |
| 12 | MP0004043_abnormal_pH_regulation | 2.12185573 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.09886289 |
| 14 | MP0009745_abnormal_behavioral_response | 2.09089158 |
| 15 | MP0002064_seizures | 2.07765874 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.07056098 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.02619499 |
| 18 | MP0001486_abnormal_startle_reflex | 2.00840067 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 1.97885699 |
| 20 | MP0002733_abnormal_thermal_nociception | 1.93695162 |
| 21 | MP0004858_abnormal_nervous_system | 1.86537014 |
| 22 | MP0002272_abnormal_nervous_system | 1.83311843 |
| 23 | MP0004742_abnormal_vestibular_system | 1.81229996 |
| 24 | MP0006276_abnormal_autonomic_nervous | 1.80737698 |
| 25 | MP0000013_abnormal_adipose_tissue | 1.79975807 |
| 26 | MP0001968_abnormal_touch/_nociception | 1.77246861 |
| 27 | MP0003787_abnormal_imprinting | 1.77077810 |
| 28 | MP0010386_abnormal_urinary_bladder | 1.73788786 |
| 29 | MP0004885_abnormal_endolymph | 1.72391224 |
| 30 | MP0002693_abnormal_pancreas_physiology | 1.71506903 |
| 31 | MP0003195_calcinosis | 1.69877699 |
| 32 | MP0005645_abnormal_hypothalamus_physiol | 1.68550906 |
| 33 | MP0001944_abnormal_pancreas_morphology | 1.68547361 |
| 34 | MP0002638_abnormal_pupillary_reflex | 1.67753300 |
| 35 | MP0009046_muscle_twitch | 1.66786616 |
| 36 | MP0005379_endocrine/exocrine_gland_phen | 1.59231200 |
| 37 | MP0001970_abnormal_pain_threshold | 1.59212819 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.54404630 |
| 39 | MP0001502_abnormal_circadian_rhythm | 1.51975856 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.50885892 |
| 41 | MP0001984_abnormal_olfaction | 1.50503041 |
| 42 | MP0000920_abnormal_myelination | 1.45105293 |
| 43 | MP0002735_abnormal_chemical_nociception | 1.44796041 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.43696855 |
| 45 | MP0000955_abnormal_spinal_cord | 1.42321147 |
| 46 | MP0006072_abnormal_retinal_apoptosis | 1.40873507 |
| 47 | MP0002067_abnormal_sensory_capabilities | 1.40581847 |
| 48 | MP0003122_maternal_imprinting | 1.39819786 |
| 49 | MP0002822_catalepsy | 1.37508274 |
| 50 | MP0002736_abnormal_nociception_after | 1.37235198 |
| 51 | MP0005167_abnormal_blood-brain_barrier | 1.37112110 |
| 52 | MP0008569_lethality_at_weaning | 1.36834529 |
| 53 | MP0005365_abnormal_bile_salt | 1.35493862 |
| 54 | MP0002184_abnormal_innervation | 1.34847394 |
| 55 | MP0000678_abnormal_parathyroid_gland | 1.30709829 |
| 56 | MP0002078_abnormal_glucose_homeostasis | 1.29539223 |
| 57 | MP0003690_abnormal_glial_cell | 1.27953414 |
| 58 | MP0001177_atelectasis | 1.27912651 |
| 59 | MP0003136_yellow_coat_color | 1.26517293 |
| 60 | MP0000778_abnormal_nervous_system | 1.25319150 |
| 61 | MP0002877_abnormal_melanocyte_morpholog | 1.25122650 |
| 62 | MP0003634_abnormal_glial_cell | 1.25073053 |
| 63 | MP0003879_abnormal_hair_cell | 1.20695954 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.20534398 |
| 65 | MP0005535_abnormal_body_temperature | 1.19956689 |
| 66 | MP0000631_abnormal_neuroendocrine_gland | 1.18549926 |
| 67 | MP0003123_paternal_imprinting | 1.18052013 |
| 68 | MP0000462_abnormal_digestive_system | 1.17368757 |
| 69 | MP0005386_behavior/neurological_phenoty | 1.16230404 |
| 70 | MP0004924_abnormal_behavior | 1.16230404 |
| 71 | MP0000566_synostosis | 1.16077071 |
| 72 | MP0005083_abnormal_biliary_tract | 1.16066751 |
| 73 | MP0002882_abnormal_neuron_morphology | 1.11113772 |
| 74 | MP0002066_abnormal_motor_capabilities/c | 1.09228047 |
| 75 | MP0003633_abnormal_nervous_system | 1.09207881 |
| 76 | MP0005085_abnormal_gallbladder_physiolo | 1.06264087 |
| 77 | MP0000604_amyloidosis | 1.06147496 |
| 78 | MP0001905_abnormal_dopamine_level | 1.04019178 |
| 79 | MP0004142_abnormal_muscle_tone | 1.02685726 |
| 80 | MP0001188_hyperpigmentation | 1.01091721 |
| 81 | MP0004811_abnormal_neuron_physiology | 1.00772328 |
| 82 | MP0001529_abnormal_vocalization | 1.00344179 |
| 83 | MP0002653_abnormal_ependyma_morphology | 0.99023725 |
| 84 | MP0003632_abnormal_nervous_system | 0.98949125 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.98109079 |
| 86 | MP0004145_abnormal_muscle_electrophysio | 0.95602409 |
| 87 | MP0001299_abnormal_eye_distance/ | 0.95317176 |
| 88 | MP0003868_abnormal_feces_composition | 0.94597760 |
| 89 | MP0001485_abnormal_pinna_reflex | 0.94190745 |
| 90 | MP0003953_abnormal_hormone_level | 0.92755814 |
| 91 | MP0003121_genomic_imprinting | 0.92709084 |
| 92 | MP0005360_urolithiasis | 0.91538955 |
| 93 | MP0002069_abnormal_eating/drinking_beha | 0.91308161 |
| 94 | MP0002752_abnormal_somatic_nervous | 0.87289243 |
| 95 | MP0003631_nervous_system_phenotype | 0.86958186 |
| 96 | MP0002229_neurodegeneration | 0.86087688 |
| 97 | MP0008961_abnormal_basal_metabolism | 0.86052136 |
| 98 | MP0005551_abnormal_eye_electrophysiolog | 0.85385627 |
| 99 | MP0003075_altered_response_to | 0.83707631 |
| 100 | MP0002234_abnormal_pharynx_morphology | 0.83119179 |
| 101 | MP0004085_abnormal_heartbeat | 0.81996402 |
| 102 | MP0002152_abnormal_brain_morphology | 0.80900575 |
| 103 | MP0000751_myopathy | 0.80466277 |
| 104 | MP0005253_abnormal_eye_physiology | 0.80262970 |
| 105 | MP0005220_abnormal_exocrine_pancreas | 0.80181865 |
| 106 | MP0001346_abnormal_lacrimal_gland | 0.79617617 |
| 107 | MP0001963_abnormal_hearing_physiology | 0.79299728 |
| 108 | MP0002876_abnormal_thyroid_physiology | 0.78150339 |
| 109 | MP0008877_abnormal_DNA_methylation | 0.77643352 |
| 110 | MP0003137_abnormal_impulse_conducting | 0.77477374 |
| 111 | MP0010329_abnormal_lipoprotein_level | 0.77020161 |
| 112 | MP0009840_abnormal_foam_cell | 0.76886016 |
| 113 | MP0002249_abnormal_larynx_morphology | 0.74471036 |
| 114 | MP0005332_abnormal_amino_acid | 0.74137723 |
| 115 | MP0008875_abnormal_xenobiotic_pharmacok | 0.74135308 |
| 116 | MP0008872_abnormal_physiological_respon | 0.73856460 |
| 117 | MP0002118_abnormal_lipid_homeostasis | 0.72641267 |
| 118 | MP0000026_abnormal_inner_ear | 0.72247926 |
| 119 | MP0003861_abnormal_nervous_system | 0.72216180 |
| 120 | MP0006292_abnormal_olfactory_placode | 0.70245904 |
| 121 | MP0000579_abnormal_nail_morphology | 0.69966383 |
| 122 | MP0003938_abnormal_ear_development | 0.69154322 |
| 123 | MP0005623_abnormal_meninges_morphology | 0.66189896 |
| 124 | MP0005499_abnormal_olfactory_system | 0.64833915 |
| 125 | MP0005394_taste/olfaction_phenotype | 0.64833915 |
| 126 | MP0008874_decreased_physiological_sensi | 0.62091804 |
| 127 | MP0004133_heterotaxia | 0.61141248 |
| 128 | MP0009379_abnormal_foot_pigmentation | 0.59838858 |
| 129 | MP0005377_hearing/vestibular/ear_phenot | 0.55830761 |
| 130 | MP0003878_abnormal_ear_physiology | 0.55830761 |
| 131 | MP0010769_abnormal_survival | 0.55482521 |
| 132 | MP0004130_abnormal_muscle_cell | 0.54450730 |
| 133 | MP0005409_darkened_coat_color | 0.53644289 |
| 134 | MP0010770_preweaning_lethality | 0.52753840 |
| 135 | MP0002082_postnatal_lethality | 0.52753840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.89305330 |
| 2 | Febrile seizures (HP:0002373) | 4.68156817 |
| 3 | Hypoglycemic seizures (HP:0002173) | 4.63435169 |
| 4 | Symptomatic seizures (HP:0011145) | 3.96403593 |
| 5 | Myokymia (HP:0002411) | 3.93770061 |
| 6 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.81794931 |
| 7 | Hypoglycemic coma (HP:0001325) | 3.81723402 |
| 8 | Focal motor seizures (HP:0011153) | 3.79325750 |
| 9 | Visual hallucinations (HP:0002367) | 3.75477409 |
| 10 | Megalencephaly (HP:0001355) | 3.56227425 |
| 11 | Ketoacidosis (HP:0001993) | 3.53978969 |
| 12 | Annular pancreas (HP:0001734) | 3.49393419 |
| 13 | Spastic gait (HP:0002064) | 3.48688093 |
| 14 | Neurofibrillary tangles (HP:0002185) | 3.32506328 |
| 15 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.29181036 |
| 16 | Pheochromocytoma (HP:0002666) | 3.23865843 |
| 17 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.15935135 |
| 18 | Agitation (HP:0000713) | 3.10798600 |
| 19 | Late onset (HP:0003584) | 3.03945429 |
| 20 | Mutism (HP:0002300) | 3.02557976 |
| 21 | Intention tremor (HP:0002080) | 2.99322765 |
| 22 | Delusions (HP:0000746) | 2.90729940 |
| 23 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.90320265 |
| 24 | Supranuclear gaze palsy (HP:0000605) | 2.89079419 |
| 25 | Cerebral inclusion bodies (HP:0100314) | 2.86392938 |
| 26 | Dysmetria (HP:0001310) | 2.85774785 |
| 27 | Cerebral hypomyelination (HP:0006808) | 2.83477936 |
| 28 | Large for gestational age (HP:0001520) | 2.83346799 |
| 29 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.81722975 |
| 30 | Postural instability (HP:0002172) | 2.81519612 |
| 31 | Focal seizures (HP:0007359) | 2.81016121 |
| 32 | EEG with generalized epileptiform discharges (HP:0011198) | 2.78860727 |
| 33 | Hypsarrhythmia (HP:0002521) | 2.77536386 |
| 34 | Sleep apnea (HP:0010535) | 2.75666725 |
| 35 | Poor eye contact (HP:0000817) | 2.75421677 |
| 36 | Urinary urgency (HP:0000012) | 2.70927092 |
| 37 | Epileptiform EEG discharges (HP:0011182) | 2.70585104 |
| 38 | Neuroendocrine neoplasm (HP:0100634) | 2.69854311 |
| 39 | Anxiety (HP:0000739) | 2.68927260 |
| 40 | Peripheral hypomyelination (HP:0007182) | 2.68336868 |
| 41 | Focal dystonia (HP:0004373) | 2.66816362 |
| 42 | Obstructive sleep apnea (HP:0002870) | 2.64125805 |
| 43 | Hemiparesis (HP:0001269) | 2.63857301 |
| 44 | Akinesia (HP:0002304) | 2.63717980 |
| 45 | Atonic seizures (HP:0010819) | 2.60460781 |
| 46 | Generalized tonic-clonic seizures (HP:0002069) | 2.60006576 |
| 47 | Ketosis (HP:0001946) | 2.58415111 |
| 48 | Abnormality of the corticospinal tract (HP:0002492) | 2.54391601 |
| 49 | Epileptic encephalopathy (HP:0200134) | 2.53871925 |
| 50 | Hyperglycemia (HP:0003074) | 2.53797007 |
| 51 | Action tremor (HP:0002345) | 2.50563353 |
| 52 | Tetraplegia (HP:0002445) | 2.49621500 |
| 53 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.48093441 |
| 54 | Aplasia of the phalanges of the hand (HP:0009802) | 2.48093441 |
| 55 | Aplasia involving bones of the extremities (HP:0009825) | 2.48093441 |
| 56 | Depression (HP:0000716) | 2.44933942 |
| 57 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.44650572 |
| 58 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.44650572 |
| 59 | Abnormal social behavior (HP:0012433) | 2.44279100 |
| 60 | Impaired social interactions (HP:0000735) | 2.44279100 |
| 61 | Craniofacial dystonia (HP:0012179) | 2.40457768 |
| 62 | Limb dystonia (HP:0002451) | 2.39454263 |
| 63 | Progressive cerebellar ataxia (HP:0002073) | 2.39311947 |
| 64 | Bradykinesia (HP:0002067) | 2.29726793 |
| 65 | Clonus (HP:0002169) | 2.29706764 |
| 66 | Abnormality of binocular vision (HP:0011514) | 2.26074469 |
| 67 | Diplopia (HP:0000651) | 2.26074469 |
| 68 | Absence seizures (HP:0002121) | 2.25261232 |
| 69 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.22804786 |
| 70 | Hemiplegia (HP:0002301) | 2.21222121 |
| 71 | Anomalous pulmonary venous return (HP:0010772) | 2.21137950 |
| 72 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.20986912 |
| 73 | Abnormality of the lower motor neuron (HP:0002366) | 2.19203216 |
| 74 | Postural tremor (HP:0002174) | 2.18847214 |
| 75 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.17904443 |
| 76 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.17904443 |
| 77 | Stereotypic behavior (HP:0000733) | 2.17694258 |
| 78 | Lower limb muscle weakness (HP:0007340) | 2.17326205 |
| 79 | Abnormal pancreas size (HP:0012094) | 2.15382081 |
| 80 | Spastic tetraparesis (HP:0001285) | 2.14427241 |
| 81 | Retinal atrophy (HP:0001105) | 2.14213603 |
| 82 | Neuronal loss in central nervous system (HP:0002529) | 2.12520338 |
| 83 | Synostosis involving the elbow (HP:0003938) | 2.12305168 |
| 84 | Humeroradial synostosis (HP:0003041) | 2.12305168 |
| 85 | Apathy (HP:0000741) | 2.08972292 |
| 86 | Restlessness (HP:0000711) | 2.08567208 |
| 87 | Broad-based gait (HP:0002136) | 2.08246118 |
| 88 | Insomnia (HP:0100785) | 2.08021678 |
| 89 | Hyperparathyroidism (HP:0000843) | 2.07533407 |
| 90 | Ventricular fibrillation (HP:0001663) | 2.06873015 |
| 91 | Dialeptic seizures (HP:0011146) | 2.05372888 |
| 92 | Truncal ataxia (HP:0002078) | 2.04190543 |
| 93 | Acute necrotizing encephalopathy (HP:0006965) | 2.03247523 |
| 94 | Hyperventilation (HP:0002883) | 2.02236650 |
| 95 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.01359528 |
| 96 | Decreased circulating renin level (HP:0003351) | 2.01352705 |
| 97 | Failure to thrive in infancy (HP:0001531) | 2.00584653 |
| 98 | Gout (HP:0001997) | 1.99586891 |
| 99 | Papilledema (HP:0001085) | 1.97935190 |
| 100 | Split foot (HP:0001839) | 1.93735032 |
| 101 | Abnormal eating behavior (HP:0100738) | 1.93229306 |
| 102 | Acute encephalopathy (HP:0006846) | 1.92733129 |
| 103 | Xanthomatosis (HP:0000991) | 1.92135810 |
| 104 | Rigidity (HP:0002063) | 1.90946061 |
| 105 | Conjugated hyperbilirubinemia (HP:0002908) | 1.90184053 |
| 106 | Status epilepticus (HP:0002133) | 1.89968030 |
| 107 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89590301 |
| 108 | Mucopolysacchariduria (HP:0008155) | 1.89590301 |
| 109 | Bronchomalacia (HP:0002780) | 1.89126151 |
| 110 | Choreoathetosis (HP:0001266) | 1.89065302 |
| 111 | Hypercortisolism (HP:0001578) | 1.88966974 |
| 112 | Abnormality of the pulmonary veins (HP:0011718) | 1.87564525 |
| 113 | Diminished motivation (HP:0000745) | 1.87453264 |
| 114 | Progressive macrocephaly (HP:0004481) | 1.86953715 |
| 115 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.86781820 |
| 116 | Ankle clonus (HP:0011448) | 1.86394854 |
| 117 | Impaired smooth pursuit (HP:0007772) | 1.85905502 |
| 118 | Absent speech (HP:0001344) | 1.82468240 |
| 119 | Truncus arteriosus (HP:0001660) | 1.82402523 |
| 120 | Impaired vibratory sensation (HP:0002495) | 1.81664394 |
| 121 | Increased circulating renin level (HP:0000848) | 1.81537789 |
| 122 | Incomplete penetrance (HP:0003829) | 1.81291896 |
| 123 | Prolonged partial thromboplastin time (HP:0003645) | 1.79462265 |
| 124 | Abnormality of the labia minora (HP:0012880) | 1.79178879 |
| 125 | Lower limb asymmetry (HP:0100559) | 1.78367094 |
| 126 | Esotropia (HP:0000565) | 1.77773312 |
| 127 | Intrahepatic cholestasis (HP:0001406) | 1.77602520 |
| 128 | CNS hypomyelination (HP:0003429) | 1.76579098 |
| 129 | Hyperlipoproteinemia (HP:0010980) | 1.76214879 |
| 130 | Unilateral renal agenesis (HP:0000122) | 1.75042313 |
| 131 | Spastic tetraplegia (HP:0002510) | 1.73831872 |
| 132 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.73625944 |
| 133 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.73625944 |
| 134 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.73625944 |
| 135 | Hypokalemia (HP:0002900) | 1.73197877 |
| 136 | Back pain (HP:0003418) | 1.71202669 |
| 137 | Torticollis (HP:0000473) | 1.70889927 |
| 138 | Prolonged QT interval (HP:0001657) | 1.70477584 |
| 139 | Polyphagia (HP:0002591) | 1.70443758 |
| 140 | Retinal dysplasia (HP:0007973) | 1.70336163 |
| 141 | Morphological abnormality of the inner ear (HP:0011390) | 1.69970734 |
| 142 | Double outlet right ventricle (HP:0001719) | 1.69910401 |
| 143 | Congenital malformation of the right heart (HP:0011723) | 1.69910401 |
| 144 | Abnormality of the intrinsic pathway (HP:0010989) | 1.69246449 |
| 145 | Amblyopia (HP:0000646) | 1.68696627 |
| 146 | Turricephaly (HP:0000262) | 1.67264891 |
| 147 | Excessive salivation (HP:0003781) | 1.67226493 |
| 148 | Drooling (HP:0002307) | 1.67226493 |
| 149 | Psychosis (HP:0000709) | 1.65662359 |
| 150 | Mixed hearing impairment (HP:0000410) | 1.65565857 |
| 151 | Dysdiadochokinesis (HP:0002075) | 1.64249658 |
| 152 | Facial shape deformation (HP:0011334) | 1.64019690 |
| 153 | Potter facies (HP:0002009) | 1.64019690 |
| 154 | Irritability (HP:0000737) | 1.63514705 |
| 155 | Type II lissencephaly (HP:0007260) | 1.61605289 |
| 156 | Hyperphosphaturia (HP:0003109) | 1.61449755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.41875025 |
| 2 | NTRK3 | 3.22804137 |
| 3 | PRKD3 | 3.20608914 |
| 4 | MARK1 | 3.05694799 |
| 5 | EPHA4 | 2.67817211 |
| 6 | PHKG2 | 2.31616584 |
| 7 | PHKG1 | 2.31616584 |
| 8 | NTRK1 | 2.28298126 |
| 9 | MAP3K9 | 2.27530632 |
| 10 | NTRK2 | 2.24397695 |
| 11 | MAP3K4 | 2.03254275 |
| 12 | MINK1 | 1.91248800 |
| 13 | UHMK1 | 1.84682471 |
| 14 | MAP3K2 | 1.82136817 |
| 15 | PASK | 1.77408601 |
| 16 | BRSK1 | 1.77027904 |
| 17 | CASK | 1.71004781 |
| 18 | TRIB3 | 1.69656799 |
| 19 | MAPK13 | 1.67061655 |
| 20 | MAP2K7 | 1.63145199 |
| 21 | LMTK2 | 1.57556875 |
| 22 | TNIK | 1.54291732 |
| 23 | GRK5 | 1.54101210 |
| 24 | MAP2K4 | 1.50794623 |
| 25 | MAPK15 | 1.49426553 |
| 26 | HIPK2 | 1.46615550 |
| 27 | MUSK | 1.45275677 |
| 28 | DAPK2 | 1.42752503 |
| 29 | PRPF4B | 1.40312629 |
| 30 | PAK6 | 1.30051581 |
| 31 | CDK5 | 1.27967915 |
| 32 | SIK1 | 1.27728404 |
| 33 | KSR2 | 1.26727087 |
| 34 | RIPK1 | 1.23945098 |
| 35 | CDK19 | 1.21395030 |
| 36 | PAK3 | 1.19192414 |
| 37 | WNK4 | 1.16749407 |
| 38 | CAMKK2 | 1.15066296 |
| 39 | SGK223 | 1.13986267 |
| 40 | SGK494 | 1.13986267 |
| 41 | CAMKK1 | 1.12538504 |
| 42 | PRKCG | 1.08612151 |
| 43 | DAPK1 | 1.07143802 |
| 44 | MAP3K1 | 1.06785668 |
| 45 | PRKCH | 1.01621869 |
| 46 | RET | 0.97950783 |
| 47 | CDK11A | 0.96286492 |
| 48 | CDC42BPA | 0.94260591 |
| 49 | SIK2 | 0.93325809 |
| 50 | ARAF | 0.93065375 |
| 51 | BCKDK | 0.91222779 |
| 52 | ADRBK1 | 0.89170068 |
| 53 | PRKCE | 0.88431595 |
| 54 | LATS2 | 0.84491053 |
| 55 | PDGFRA | 0.83742164 |
| 56 | CAMK2A | 0.83390286 |
| 57 | DYRK1A | 0.83287430 |
| 58 | NEK6 | 0.81465840 |
| 59 | PRKD2 | 0.80328388 |
| 60 | CAMK2B | 0.79755692 |
| 61 | TAOK3 | 0.77360954 |
| 62 | WEE1 | 0.76855776 |
| 63 | TNK2 | 0.76104339 |
| 64 | SGK2 | 0.75070542 |
| 65 | KSR1 | 0.72098266 |
| 66 | PNCK | 0.71209110 |
| 67 | PINK1 | 0.70754678 |
| 68 | CAMK4 | 0.68195278 |
| 69 | CAMK2G | 0.67402034 |
| 70 | MAPK10 | 0.65825602 |
| 71 | NME1 | 0.64858107 |
| 72 | DDR2 | 0.63216780 |
| 73 | MARK2 | 0.62685625 |
| 74 | ALK | 0.62252515 |
| 75 | MAP3K11 | 0.61852992 |
| 76 | IRAK2 | 0.61522346 |
| 77 | CAMK2D | 0.61218998 |
| 78 | MAP2K2 | 0.59397753 |
| 79 | PRKACA | 0.57777470 |
| 80 | MAP2K1 | 0.57506975 |
| 81 | CSNK1G2 | 0.56782926 |
| 82 | WNK3 | 0.56058193 |
| 83 | BRAF | 0.55282697 |
| 84 | PTK2 | 0.55112097 |
| 85 | PRKACG | 0.54591753 |
| 86 | PRKCZ | 0.54380286 |
| 87 | DYRK2 | 0.53669071 |
| 88 | MAPK12 | 0.53196023 |
| 89 | CDK14 | 0.53185253 |
| 90 | DAPK3 | 0.52700462 |
| 91 | ROCK2 | 0.52034873 |
| 92 | SGK3 | 0.51797590 |
| 93 | PTK6 | 0.50635026 |
| 94 | PKN1 | 0.50569559 |
| 95 | STK38 | 0.50444572 |
| 96 | TYRO3 | 0.49524079 |
| 97 | CAMK1G | 0.49361588 |
| 98 | FRK | 0.48081042 |
| 99 | LIMK1 | 0.47756957 |
| 100 | SCYL2 | 0.47723121 |
| 101 | FES | 0.46534355 |
| 102 | CDK15 | 0.46251058 |
| 103 | STK11 | 0.46111254 |
| 104 | CDK18 | 0.45862893 |
| 105 | FGFR2 | 0.45812784 |
| 106 | WNK1 | 0.45126184 |
| 107 | FER | 0.44628723 |
| 108 | RPS6KA3 | 0.44273314 |
| 109 | CAMK1 | 0.43330570 |
| 110 | SGK1 | 0.42899746 |
| 111 | DYRK1B | 0.42699409 |
| 112 | PRKAA1 | 0.42007886 |
| 113 | CSNK1G3 | 0.41857353 |
| 114 | ERN1 | 0.41820210 |
| 115 | PDPK1 | 0.41244527 |
| 116 | IRAK1 | 0.41048191 |
| 117 | PRKCA | 0.40781157 |
| 118 | PRKD1 | 0.40725970 |
| 119 | TSSK6 | 0.40586947 |
| 120 | MAPKAPK5 | 0.40491628 |
| 121 | ROCK1 | 0.39994569 |
| 122 | PLK2 | 0.39968725 |
| 123 | CAMK1D | 0.38983773 |
| 124 | PRKG1 | 0.37767538 |
| 125 | ERBB2 | 0.37739418 |
| 126 | OXSR1 | 0.37547919 |
| 127 | BRSK2 | 0.36091351 |
| 128 | CSNK1A1L | 0.34759272 |
| 129 | RIPK4 | 0.33992009 |
| 130 | PRKG2 | 0.33614193 |
| 131 | MAPK4 | 0.32776570 |
| 132 | CSNK1A1 | 0.32227606 |
| 133 | CCNB1 | 0.31422004 |
| 134 | CSNK1D | 0.31259932 |
| 135 | FYN | 0.30545502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.50805576 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.06697778 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 2.61465557 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.14776766 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.10741769 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.05641444 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.00606558 |
| 8 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.89763009 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.85584218 |
| 10 | Cocaine addiction_Homo sapiens_hsa05030 | 1.76321106 |
| 11 | Protein export_Homo sapiens_hsa03060 | 1.72158378 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.64677894 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.62573730 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 1.61618654 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.60089925 |
| 16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.59973332 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.58196502 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.49151914 |
| 19 | Long-term potentiation_Homo sapiens_hsa04720 | 1.46340356 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.46206992 |
| 21 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.46164289 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 1.44805293 |
| 23 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.40511112 |
| 24 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.35030560 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.29273050 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.26339724 |
| 27 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.25089706 |
| 28 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.21796672 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.19034805 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.16944253 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.15628328 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.15591612 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.11835256 |
| 34 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.08348259 |
| 35 | Olfactory transduction_Homo sapiens_hsa04740 | 1.07757512 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.03370597 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.02375761 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.02112614 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01915348 |
| 40 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01706849 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.00415349 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.00090325 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.99956343 |
| 44 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96985385 |
| 45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.95992341 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94564508 |
| 47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93951937 |
| 48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.93664687 |
| 49 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.92642918 |
| 50 | Long-term depression_Homo sapiens_hsa04730 | 0.92021634 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.91716740 |
| 52 | Parkinsons disease_Homo sapiens_hsa05012 | 0.89625800 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87737053 |
| 54 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.87595489 |
| 55 | Renin secretion_Homo sapiens_hsa04924 | 0.85465962 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.84899623 |
| 57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84203423 |
| 58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83630202 |
| 59 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.82513918 |
| 60 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82364719 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82349660 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81818166 |
| 63 | Gap junction_Homo sapiens_hsa04540 | 0.81236796 |
| 64 | Glioma_Homo sapiens_hsa05214 | 0.80835697 |
| 65 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80617811 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80153025 |
| 67 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79551291 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 0.79139818 |
| 69 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.77509958 |
| 70 | Melanogenesis_Homo sapiens_hsa04916 | 0.77009233 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75710952 |
| 72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.75113788 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.72219697 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71736829 |
| 75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70866770 |
| 76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.66552982 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.65776911 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.64829589 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64609144 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64405831 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63205396 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60783030 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60114171 |
| 84 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59242595 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58809252 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.58809068 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58135078 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57676556 |
| 89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57210666 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57063968 |
| 91 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.57051174 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56186569 |
| 93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54682206 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.54106392 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52670481 |
| 96 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52120493 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52069436 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51159095 |
| 99 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.50434958 |
| 100 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49812538 |
| 101 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49488101 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.49231134 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48999291 |
| 104 | Axon guidance_Homo sapiens_hsa04360 | 0.48746052 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47206879 |
| 106 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46439367 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46379040 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46207921 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46073258 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45355205 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.44952304 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44933853 |
| 113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44886526 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.44343869 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43933279 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42977058 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.40838224 |
| 118 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.39968712 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39695400 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.38476589 |
| 121 | Peroxisome_Homo sapiens_hsa04146 | 0.38251150 |
| 122 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37837883 |
| 123 | Huntingtons disease_Homo sapiens_hsa05016 | 0.37615166 |
| 124 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.37435952 |
| 125 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.35082795 |
| 126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34935918 |
| 127 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34849633 |
| 128 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.32984649 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27346734 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.25244622 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.23450051 |
| 132 | Tight junction_Homo sapiens_hsa04530 | 0.20458768 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.18353069 |

